0.2785
price up icon21.62%   0.0495
after-market 시간 외 거래: .28 0.0015 +0.54%
loading
전일 마감가:
$0.229
열려 있는:
$0.234
하루 거래량:
3.71M
Relative Volume:
11.55
시가총액:
$43.77M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-0.0296
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
+23.18%
1개월 성능:
-7.17%
6개월 성능:
-66.53%
1년 성능:
-82.59%
1일 변동 폭
Value
$0.2263
$0.30
1주일 범위
Value
$0.2108
$0.30
52주 변동 폭
Value
$0.1706
$4.00

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
명칭
Cyclacel Pharmaceuticals Inc
Name
전화
908-517-7330
Name
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
CYCC's Discussions on Twitter

CYCC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CYCC
Cyclacel Pharmaceuticals Inc
0.2785 43.77M 74,000 -13.43M -10.54M -9.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-07-18 재개 Oppenheimer Outperform
2020-04-27 재개 ROTH Capital Buy
2018-09-07 개시 Ladenburg Thalmann Buy
2015-10-16 개시 H.C. Wainwright Buy
2010-02-04 개시 Roth Capital Buy
2009-10-28 개시 Merriman Buy
2008-08-12 개시 Piper Jaffray Buy
2008-03-12 재확인 Cantor Fitzgerald Buy
2008-03-12 재확인 Collins Stewart Buy
2008-03-12 재확인 Needham & Co Buy
2007-11-27 재확인 Cantor Fitzgerald Buy
2007-08-10 재확인 Cantor Fitzgerald Buy
2007-06-04 재확인 Needham & Co Buy
2007-04-23 개시 Lazard Capital Buy
2007-04-10 개시 Cantor Fitzgerald Buy
모두보기

Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스

pulisher
04:55 AM

Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India

04:55 AM
pulisher
03:48 AM

Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus

03:48 AM
pulisher
03:12 AM

Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com

03:12 AM
pulisher
01:22 AM

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel

01:22 AM
pulisher
Apr 24, 2025

Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 21, 2025

Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada

Apr 21, 2025
pulisher
Apr 16, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World

Apr 16, 2025
pulisher
Apr 07, 2025

When (CYCCP) Moves Investors should Listen - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 05, 2025

Cyclacel Pharmaceuticals Inc (CYCC) Q2 2024 Earnings Call Transc - GuruFocus

Apr 05, 2025
pulisher
Apr 05, 2025

Fitters Diversified To Dispose Subsidiary To Nasdaq Listed Pharma Firm - businesstoday.com.my

Apr 05, 2025
pulisher
Apr 04, 2025

Fitters plans to sell full stake in unit to US biotech firm - The Malaysian Reserve

Apr 04, 2025
pulisher
Apr 03, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times

Apr 03, 2025
pulisher
Apr 03, 2025

Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development - TipRanks

Apr 03, 2025
pulisher
Apr 02, 2025

Cyclacel Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results And Provides Business Update - MarketScreener

Apr 02, 2025
pulisher
Mar 31, 2025

Cyclacel Pharmaceuticals Delays 10-K Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Cyclacel Pharmaceuticals to offer convertible preferred stock in private placement - MSN

Mar 26, 2025
pulisher
Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering Of Convertible Preferred Stock - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - The Manila Times

Mar 24, 2025
pulisher
Mar 24, 2025

Cyclacel's Latest $1M Financing Deal Reveals Extended Survival Strategy Through Q3 2025 - Stock Titan

Mar 24, 2025
pulisher
Mar 23, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

Mar 23, 2025
pulisher
Mar 17, 2025

Cyclacel Pharmaceuticals’ Change of Control Transaction and Appointment of New Executive Leadership - Global Legal Chronicle

Mar 17, 2025
pulisher
Mar 17, 2025

(CYCCP) Trading Advice - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 16, 2025

Cyclacel Pharmaceuticals (CYCC) Projected to Post Earnings on Tuesday - The AM Reporter

Mar 16, 2025
pulisher
Mar 15, 2025

CYCLACEL PHARMACEUTICALS Earnings Preview: Recent $CYCC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets By Investing.com - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets - Investing.com

Mar 14, 2025
pulisher
Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

Cyclacel stock plunges to 52-week low of $0.31 amid market challenges - MSN

Mar 09, 2025
pulisher
Mar 07, 2025

Cyclacel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 28, 2025

Cyclacel Pharmaceuticals interim CEO David Lazar sells $5.5 million in stock - Investing.com India

Feb 28, 2025
pulisher
Feb 27, 2025

Cyclacel Pharmaceuticals Announces New Leadership and Restructuring - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cyclacel Pharmaceuticals Says Datuk Dr.Doris Wong Sing Ee Elected As CEO & Executive Director - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Cyclacel Pharmaceuticals Expands Executive Leadership Team - citybiz

Feb 27, 2025

Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):